medicine

New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis

Nearly half of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete renal response (CRR), with a statistically significant and...

Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review | BMC Medicine

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11.Article  Google Scholar  Yuan Q, Zhang H,...